177 related articles for article (PubMed ID: 27857131)
21. miR-137 and miR-197 Induce Apoptosis and Suppress Tumorigenicity by Targeting MCL-1 in Multiple Myeloma.
Yang Y; Li F; Saha MN; Abdi J; Qiu L; Chang H
Clin Cancer Res; 2015 May; 21(10):2399-411. PubMed ID: 25724519
[TBL] [Abstract][Full Text] [Related]
22. miR-17-92 cluster microRNAs confers tumorigenicity in multiple myeloma.
Chen L; Li C; Zhang R; Gao X; Qu X; Zhao M; Qiao C; Xu J; Li J
Cancer Lett; 2011 Oct; 309(1):62-70. PubMed ID: 21664042
[TBL] [Abstract][Full Text] [Related]
23. ShRNA-mediated Bmi-1 silencing sensitizes multiple myeloma cells to bortezomib.
Wu SQ; Xu ZZ; Niu WY; Huang HB; Zhan R
Int J Mol Med; 2014 Aug; 34(2):616-23. PubMed ID: 24913180
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-873 mediates multidrug resistance in ovarian cancer cells by targeting ABCB1.
Wu DD; Li XS; Meng XN; Yan J; Zong ZH
Tumour Biol; 2016 Aug; 37(8):10499-506. PubMed ID: 26850595
[TBL] [Abstract][Full Text] [Related]
25. miR-218 contributes to drug resistance in multiple myeloma via targeting LRRC28.
Chen H; Cao W; Chen J; Liu D; Zhou L; Du F; Zhu F
J Cell Biochem; 2021 Apr; 122(3-4):305-314. PubMed ID: 33417267
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic silencing of miR-137 contributes to early colorectal carcinogenesis by impaired Aurora-A inhibition.
Huang YC; Lee CT; Lee JC; Liu YW; Chen YJ; Tseng JT; Kang JW; Sheu BS; Lin BW; Hung LY
Oncotarget; 2016 Nov; 7(47):76852-76866. PubMed ID: 27764771
[TBL] [Abstract][Full Text] [Related]
27. Potential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myeloma.
Zhang L; Pan L; Xiang B; Zhu H; Wu Y; Chen M; Guan P; Zou X; Valencia CA; Dong B; Li J; Xie L; Ma H; Wang F; Dong T; Shuai X; Niu T; Liu T
Oncotarget; 2016 May; 7(21):30876-91. PubMed ID: 27129167
[TBL] [Abstract][Full Text] [Related]
28. miR-196b Is Epigenetically Silenced during the Premalignant Stage of Lung Carcinogenesis.
Tellez CS; Juri DE; Do K; Picchi MA; Wang T; Liu G; Spira A; Belinsky SA
Cancer Res; 2016 Aug; 76(16):4741-51. PubMed ID: 27302168
[TBL] [Abstract][Full Text] [Related]
29. miR-320a regulates cell proliferation and apoptosis in multiple myeloma by targeting pre-B-cell leukemia transcription factor 3.
Lu Y; Wu D; Wang J; Li Y; Chai X; Kang Q
Biochem Biophys Res Commun; 2016 May; 473(4):1315-1320. PubMed ID: 27086852
[TBL] [Abstract][Full Text] [Related]
30. miR-124 suppresses glioblastoma growth and potentiates chemosensitivity by inhibiting AURKA.
Qiao W; Guo B; Zhou H; Xu W; Chen Y; Liang Y; Dong B
Biochem Biophys Res Commun; 2017 Apr; 486(1):43-48. PubMed ID: 28242198
[TBL] [Abstract][Full Text] [Related]
31. RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myeloma.
Viziteu E; Klein B; Basbous J; Lin YL; Hirtz C; Gourzones C; Tiers L; Bruyer A; Vincent L; Grandmougin C; Seckinger A; Goldschmidt H; Constantinou A; Pasero P; Hose D; Moreaux J
Leukemia; 2017 Oct; 31(10):2104-2113. PubMed ID: 28186131
[TBL] [Abstract][Full Text] [Related]
32. Deletion of Chromosomal Region 8p21 Confers Resistance to Bortezomib and Is Associated with Upregulated Decoy TRAIL Receptor Expression in Patients with Multiple Myeloma.
Duru AD; Sutlu T; Wallblom A; Uttervall K; Lund J; Stellan B; Gahrton G; Nahi H; Alici E
PLoS One; 2015; 10(9):e0138248. PubMed ID: 26378933
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia.
Agirre X; Vilas-Zornoza A; Jiménez-Velasco A; Martin-Subero JI; Cordeu L; Gárate L; San José-Eneriz E; Abizanda G; Rodríguez-Otero P; Fortes P; Rifón J; Bandrés E; Calasanz MJ; Martín V; Heiniger A; Torres A; Siebert R; Román-Gomez J; Prósper F
Cancer Res; 2009 May; 69(10):4443-53. PubMed ID: 19435910
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic repression of miR-375 is the dominant mechanism for constitutive activation of the PDPK1/RPS6KA3 signalling axis in multiple myeloma.
Tatekawa S; Chinen Y; Ri M; Narita T; Shimura Y; Matsumura-Kimoto Y; Tsukamoto T; Kobayashi T; Kawata E; Uoshima N; Taki T; Taniwaki M; Handa H; Iida S; Kuroda J
Br J Haematol; 2017 Aug; 178(4):534-546. PubMed ID: 28439875
[TBL] [Abstract][Full Text] [Related]
35. Genomic screening for genes silenced by DNA methylation revealed an association between RASD1 inactivation and dexamethasone resistance in multiple myeloma.
Nojima M; Maruyama R; Yasui H; Suzuki H; Maruyama Y; Tarasawa I; Sasaki Y; Asaoku H; Sakai H; Hayashi T; Mori M; Imai K; Tokino T; Ishida T; Toyota M; Shinomura Y
Clin Cancer Res; 2009 Jul; 15(13):4356-64. PubMed ID: 19549772
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms underlying the increased chemosensitivity of bortezomib-resistant multiple myeloma by silencing nuclear transcription factor Snail1.
Huang Z; Liang X; Wu W; Chen X; Zeng Q; Yang M; Ge J; Xia R
Oncol Rep; 2019 Jan; 41(1):415-426. PubMed ID: 30365089
[TBL] [Abstract][Full Text] [Related]
37. [Mechanism and Clinical Significance of miR-373 In Elderly Patients with Multiple Myeloma].
Wang H; Li J; Liu YC; Chen X; Chai T
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun; 26(3):829-835. PubMed ID: 29950228
[TBL] [Abstract][Full Text] [Related]
38. Identification and characterization of deschloro-chlorothricin obtained from a large natural product library targeting aurora A kinase in multiple myeloma.
Özenver N; Abdelfatah S; Klinger A; Fleischer E; Efferth T
Invest New Drugs; 2021 Apr; 39(2):348-361. PubMed ID: 32978717
[TBL] [Abstract][Full Text] [Related]
39. Epigenetically altered miR-1247 functions as a tumor suppressor in pancreatic cancer.
Yi JM; Kang EJ; Kwon HM; Bae JH; Kang K; Ahuja N; Yang K
Oncotarget; 2017 Apr; 8(16):26600-26612. PubMed ID: 28460450
[TBL] [Abstract][Full Text] [Related]
40. Genetic and epigenetic silencing of mircoRNA-506-3p enhances COTL1 oncogene expression to foster non-small lung cancer progression.
Guo S; Yang P; Jiang X; Li X; Wang Y; Zhang X; Sun B; Zhang Y; Jia Y
Oncotarget; 2017 Jan; 8(1):644-657. PubMed ID: 27893417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
